BioSpace News Archive

Proton Therapy Partners and CHAMPS Oncology are collaborating to create customized cancer data reports through CHAMPS’ insight2oncology® system.

Leidos will enable its customers to deliver Clarify-generated observed and predictive insights directly into healthcare operations through its careC2 platform.

Helix BioPharma Corp. announced it has closed a private placement financing of 2,940,000 units of the Company and the disposition of shares of the Company’s Polish subsidiary, Helix Immuno-Oncology S.A., representing an 8.5% stake in HIO for aggregate gross proceeds of approximately CAD $3,000,000, or $1.02 per Purchased Security.

The Barer Institute, a collaborative cancer drug development initiative of Rafael Holdings, Inc., announced the slate of highly regarded scientific and business leaders that will serve as its founding Board of Directors.

Diagnosing CVD is the first step in patients’ road to recovery. It is imperative to detect the disease early in order to administer treatment while it is still treatable. In addition, preventing the disease altogether is becoming more important in healthcare.

etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication.

Mr. DiPofi brings vast experience to 50 year old company experiencing a resurgence in market share.

Strategic acquisition will streamline services, control costs, and ensure compliance

Total revenue for the fourth quarter of 2019 expected to be $11.6 - $11.8 million, compared to $11.5 million in the fourth quarter of 2018.

Ms. Schmidt will join Arena formally in March 2020 and report to Amit D. Munshi, Arena’s President and Chief Executive Officer.